Dr. James G. Chelnis, MD

Dr. Chelnis practices at Surgicare of Central Jersey in Watchung, New Jersey.

Dr. Chelnis' NPI, 1952612913, was assigned on June 24, 2010. Dr. Chelnis graduated from Jacobs School of Medicine and Biomedical Sciences in 2010. Dr. Chelnis holds New York license 283059-1.

Dr. Chelnis' primary practice is Surgicare of Central Jersey, at 40 Stirling Road, Watchung, NJ 07069. The practice phone is (908) 769-8000.

Dr. Chelnis' primary practice is Surgicare of Central Jersey in Watchung, New Jersey. Dmand AI also links Dr. Chelnis to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chelnis practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Chelnis' primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Chelnis is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chelnis' licenses on file in 5 states: New York, Massachusetts, New Jersey, Texas and Tennessee.

Dmand AI lists dry eye and eyelid inflammation among the conditions Dr. Chelnis treats.

CMS data shows 336 Medicare services from Dr. Chelnis across 6 procedure codes in 2024, for 118 Medicare patients. Medicare paid $20,604 for them. Every service was in an office.

CMS counts 118 Medicare patients who saw Dr. Chelnis in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high cholesterol, and 57% have high blood pressure. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chelnis' median patient age at 56, with 59% women.

In 2024, Dr. Chelnis wrote 215 Medicare Part D claims for 73 patients. 83% of them were for generic drugs. CMS names the drug for 113 of them, across 4 drugs with 11 or more claims each, at $1,166 in total drug cost. In 2023, CMS named 125 claims across 4 drugs.

Dr. Chelnis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Chelnis, published from 2012 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Magnetic Resonance Imaging, Tomography, X-Ray Computed and Diagnosis, Differential. Dr. Chelnis has published most often in Ophthalmic Plast Reconstr Surg. Dr. Chelnis' most frequent co-authors are Raj K. Shrivastava, MD, Joshua B. Bederson, MD and Brian T. Fowler, MD.

Dmand AI links Dr. Chelnis to 1 clinical trial. Conditions studied include Blepharoptosis and Eyelid Diseases.

CMS Open Payments shows 237 general payments to Dr. Chelnis from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Lumenis BE inc paid the most, $148,578.

Dmand AI lists 3 awards for Dr. Chelnis.

Dr. Chelnis graduated from Jacobs School of Medicine and Biomedical Sciences in 2010.

Dr. Chelnis is in network with 18 carriers, including Aetna, Elevance and Horizon Blue Cross Blue Shield of New Jersey. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.